Hostname: page-component-7479d7b7d-q6k6v Total loading time: 0 Render date: 2024-07-12T14:51:46.365Z Has data issue: false hasContentIssue false

The Association Between State-Level Prenatal Substance Use Policies and Rates of Maternal Mortality in the United States: A Legal Epidemiology Study

Published online by Cambridge University Press:  12 July 2024

Abstract

Little research has explored relationships between prenatal substance use policies and rates of maternal mortality across all 50 states, despite evidence that prenatal substance use elevates risk of maternal death. This study, utilizing publicly available data, revealed that state-level mandated testing laws predicted maternal mortality after controlling for population characteristics.

Type
Symposium Articles
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hoyert, D.L., National Center for Health Statistics, ,Maternal Mortality Rates in the United States 2019 (2021), available at <https://doi.org/10.15620/cdc:103855>.Google Scholar
Schiff, D.M. et al., “Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.” American Journal of Obstetrics and Gynecology 225 no. 4 (2021): 4P24. E1–424.E12; Maryland Department of Health and Mental Hygiene, Maryland Maternal Mortality Review: 2016 Annual Report (January 13, 2017); E.L. Wolfe et al., “Mortality risk associated with perinatal drug and alcohol use in California.” Journal of Perinatology 25(2) (2005): 93–100.CrossRefGoogle ScholarPubMed
Cleveland, L.M. et al., “A life-course theory exploration of opioid-related maternal mortality in the United States.” Addiction 115 no. 11 (2020): 20792088.CrossRefGoogle ScholarPubMed
See Wolfe et al, supra note 2.Google Scholar
Substance Use During Pregnancy (2020), Guttmacher Institute. available at <https://www.guttmacher.org/state- policy/explore/substance-use-during-pregnancy> (last visited August 12, 2023); Faherty, L.J. et al., “Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome.” JAMA Network Open 2 no. 11 (2019): e1914078e1914078; C. Dailard and E. Nash, “State Responses to Substance Abuse Among Pregnant Women.” The Guttmacher Report on Public Policy 3 no. 6 (2000): 3–6.CrossRefGoogle ScholarPubMed
See Faherty et al., supra note 5.Google Scholar
Gopman, S., “Prenatal and Postpartum Care of Women With Substance Use Disorders.” Obstetrics and Gynecology Clinics 41 no. 2 (2014): 213228.Google ScholarPubMed
Paltrow, L.M. and Flavin, J., “Arrests of and Forced Interventions on Pregnant Women in the United States, 1973–2005: Implications for Women’s Legal Status and Public Health.” Journal of Health Politics, Policy and Law 38 no. 2 (2013): 299343.CrossRefGoogle ScholarPubMed
See Faherty et al., supra note 5.Google Scholar
See Faherty et al., supra note 5.Google Scholar
Ramanathan, T. et al., “Legal Epidemiology: the Science of Law.” Journal of Law, Medicine & Ethics 45 no. 1 supplement (2017): 6972.CrossRefGoogle ScholarPubMed
United Health Foundation: America’s Health Rankings, 2020 Health of Women and Children Report, (2021), available at <https://assets.americashealthrankings.org/app/uploads/2020-hwc-report.csv> (last visited March 3, 2024).+(last+visited+March+3,+2024).>Google Scholar
Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP) Fast Stats: Neonatal Abstinence Syndrome (NAS), National & State (2018), available at <https://datatools.ahrq.gov/hcup-fast-stats?tab=special-emphasis&dash=83> (last visited March 3, 2024).+(last+visited+March+3,+2024).>Google Scholar
Osterman, M.J.K. and Martin, J.A, “System Timing and Adequacy of Prenatal Care in the United States, 2016,” National Vital Statistics reports 67 no. 3 (2018): 114.Google Scholar
Explore Census Data (2020), U.S. Census Bureau, available at <https://data.census.gov/> (last visited 2021).+(last+visited+2021).>Google Scholar
Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health (2018), available at <https://www.samhsa.gov/data/release/2018-national-survey-drug-use-and-health-nsduh-releases> (last visited March 3, 2024).+(last+visited+March+3,+2024).>Google Scholar
See Faherty et al., supra note 5.Google Scholar
See Wolfe et al, supra note 2; Centers for Disease Control and Prevention, Pregnancy-Related Deaths: Data from 14 U.S. Maternal Mortality Review Committees, 2008-2017 (2019), available at <https://www.cdc.gov/reproductivehealth/maternal-mortality/erase-mm/mmr-data-brief.html>..>Google Scholar
Noursi, S. et al., “Maternal Morbidity and Mortality,” Journal of Women’s Health 30 no. 2 (2021): 145146; G.K. Singh “Trends and Social Inequalities in Maternal Mortality in the United States, 1969-2018.” International Journal of Maternal and Child Health and AIDS 10 no. 1 (2021): 29; M.J. Tucker et al., “The Black–White Disparity in Pregnancy-related Mortality From 5 Conditions: Differences in Prevalence and Case-Fatality Rates.” American Journal of Public Health 97 no. 2 (2007): 247–251; S. Partridge et al., 2012. “Inadequate Prenatal Care Utilization and Risks of Infant Mortality and Poor Birth Outcome: a Retrospective Analysis of 28,729,765 US Deliveries Over 8 Years.” American Journal of Perinatology 29 no. 10 (2012): 787–794.CrossRefGoogle ScholarPubMed
See Partridge et al., supra note 19; Howell, E.A. et al., “Black-White Differences in Severe Maternal Morbidity and Site of Care.” American Journal of Obstetrics and Gynecology 214 no. 1 (2016): 122.e1122.e7.CrossRefGoogle ScholarPubMed
See Noursi et al, supra note 19; Singh, supra note 19; Tucker et al., supra note 19; Partridge et al., supra note 19; Howell et al., supra note 20; Vintzileos, A.M. et al., “The impact of prenatal care on neonatal deaths in the presence and absence of antenatal high-risk conditions.” American Journal of Obstetrics and Gynecology 186 no. 5 (2002): 10111016.CrossRefGoogle ScholarPubMed
See Paltrow and Flavin, supra note 8.Google Scholar
Ondersma, S.J. et al., “Prenatal Drug Exposure and Social Policy: The Search for an Appropriate Response.” Child Maltreatment 5 no. 2 (2000): 93108.CrossRefGoogle ScholarPubMed